Skip to content

Your cart is empty

Have an account? Log in to check out faster.

Continue shopping
Used by Mounjaro & Wegovy patients across the UK

The UK's most complete GLP-1 guide

Every Question Answered. Every Side Effect Explained.

  • How GLP-1 medications work
  • Mounjaro vs Wegovy compared
  • Injection instructions
  • Side effects & solutions
  • What to eat on treatment
  • FAQs answered
Get the guide + free tracker — £1.99 →

Free tracker included with every download this week

GLP-1 Medication Guide — 11 chapters, 100+ pages, NHS-aligned with free 52-week weight loss tracker calendar
Free · Instant · No sign-up required

Mounjaro Dry Mouth vs Wegovy: Which Causes More?

Dry mouth is a recognised side effect reported with both Mounjaro (tirzepatide) and Wegovy (semaglutide), though it's not listed as a very common side effect for either medication in UK clinical data. Both are prescription-only weight management injections, but they work through different mechanisms—Mounjaro is a dual GIP and GLP-1 receptor agonist, while Wegovy activates GLP-1 only. Side effect profiles differ slightly between the two, and how your body responds depends on individual factors, dose, and duration of treatment. Your prescriber will assess which medication suits you best.

10,000+ calculations today · NHS-aligned thresholds · 100% free

26%of UK adults are living with obesityNHS Digital, 2023
64%of adults in England are overweight or obeseHealth Survey for England
£6.5bnannual cost of obesity to the NHSPublic Health England
4.7Mpeople in England eligible for weight loss drugsNICE estimates, 2024

Calculate Your BMI Instantly

Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.

What Is BMI and Why Does It Matter?

Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).

While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.

Below 18.5Underweight
18.5 – 24.9Healthy
25 – 29.9Overweight
30+Obese

The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.

How Mounjaro and Wegovy Differ in Mechanism and Side Effects

Mounjaro (tirzepatide) activates two hormone pathways simultaneously—GIP (glucose-dependent insulinotropic polypeptide) and GLP-1. This dual mechanism may contribute to a broader range of side effects compared to single-pathway medications. In clinical trials, gastrointestinal effects like nausea, diarrhoea, and constipation are more commonly reported than dry mouth.

Wegovy (semaglutide) targets GLP-1 only, which may result in a different side effect profile. Nausea and gastrointestinal symptoms dominate reported side effects, with dry mouth mentioned less frequently.

Neither medication lists dry mouth as a "very common" side effect in UK prescribing information, though it has been reported anecdotally by some patients. If you experience dry mouth while taking either medication, your GP or prescriber can advise whether it's related to the injection, dehydration, or another factor.

Clinically Backed
Weight Loss

No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.

Get Started →Plans from £144.99/month
AdNew here?
£30OFF
On All Weight Loss Orders
Use Code: FIRST30
GPhC Regulated
Same-day Rx
Next-day Delivery
Genuine Medication

How It Works

Three simple steps to understand your weight and take action.

1Check Your BMI

Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.

2Explore Your Options

If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.

3Track Your Progress

Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.

Free Weight Loss Tools & Guides

Everything you need to understand your weight, explore medication options, and track your progress — completely free.

Clinical Trial Data and Individual Suitability

The SURMOUNT-1 trial (Mounjaro) and STEP-1 trial (Wegovy) both measured weight loss and side effects across thousands of participants. Importantly, neither trial flagged dry mouth as a defining difference between the two medications. Side effect frequency and severity vary significantly between individuals—what affects one person may not affect another.

Your prescriber will consider your medical history, other medications, and any previous side effects you've experienced with similar treatments when deciding which medication to recommend. Both require a clinical assessment before prescription. Use our GLP-1 weight loss calculator to explore projected outcomes at different doses, and our BMI calculator to understand your starting point before discussing treatment with your GP or a licensed prescriber.

Mounjaro (Tirzepatide)
  • Dual GIP/GLP-1 receptor agonist
  • Up to 22.5% body weight loss (SURMOUNT-1)
  • Weekly injection, dose escalation over 20+ weeks
  • Available via private prescription in the UK
  • Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
Read our full Mounjaro guide →
Wegovy (Semaglutide)
  • GLP-1 receptor agonist
  • Up to 15–17% body weight loss (STEP trials)
  • Weekly injection, 5-step dose escalation
  • NHS & private prescription available
  • Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Read our full Wegovy guide →

Mounjaro vs Wegovy: Head-to-Head

A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.

FeatureMounjaroWegovy
Drug classDual GIP/GLP-1 agonistGLP-1 agonist
Active ingredientTirzepatideSemaglutide
Avg. weight loss15–22.5%12–17%
Key trialSURMOUNT-1 (2022)STEP 1 (2021)
Max dose15 mg weekly2.4 mg weekly
Escalation period20–32 weeks16–20 weeks
AdministrationWeekly injection (pen)Weekly injection (pen)
NHS availabilityPrivate prescription onlyNHS & private
Approx. private cost£150–£250/month£150–£300/month
Common side effectsNausea, diarrhoea, constipationNausea, vomiting, diarrhoea

Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.

Am I Eligible for Weight Loss Medication?

In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.

Standard eligibility
  • BMI of 30 or above (obese)
  • Age 18 or over
  • No contraindicated conditions
  • Committed to lifestyle changes
With comorbidities
  • BMI of 27 or above
  • Plus type 2 diabetes
  • Or high blood pressure
  • Or obstructive sleep apnoea

Use our BMI calculator to check whether your BMI falls within the eligible range.

How We Built These Tools

Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.

All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.

We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.

Frequently Asked Questions

Common questions about BMI, weight loss medications, and our free UK tools.

Does Mounjaro cause more dry mouth than Wegovy?

No published clinical trial data directly compares dry mouth rates between the two. Both medications report it infrequently. Individual responses vary. Dry mouth may be related to dose, dehydration, or other factors. Your prescriber can help identify the cause and recommend management strategies.

What's the main difference between Mounjaro and Wegovy?

Mounjaro (tirzepatide) is a dual GIP+GLP-1 receptor agonist, while Wegovy (semaglutide) activates GLP-1 only. Mounjaro's dual mechanism may produce slightly different side effects. Average weight loss in trials is comparable, but individual results vary significantly.

How common is dry mouth with Mounjaro?

Dry mouth is not listed as a "very common" or "common" side effect of Mounjaro in UK prescribing information. If you experience it, mention it to your GP or prescriber—it may be manageable with increased water intake or other simple measures.

Is dry mouth worse at higher Mounjaro doses?

Side effects, including dry mouth, can intensify as doses increase. Mounjaro starts at 2.5 mg and escalates gradually to a maximum of 15 mg. Your prescriber monitors side effects at each dose level and adjusts your treatment accordingly.

Which medication should I choose if I'm concerned about dry mouth?

Neither Mounjaro nor Wegovy lists dry mouth as a major side effect, so choice shouldn't be based on this alone. Your prescriber will recommend the most suitable medication based on your medical history, eligibility, NHS or private access, and other health factors. Both require a clinical assessment.

Ready to take control of your weight loss journey?

Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.

Search